In mice, bile acid-induced TGR5 activation in BAT increases energy expenditure by inducing the cAMP-dependent thyroid hormone-activating enzyme known as type 2 iodothyronine deiodinase (D2), leading to improved obesity tolerance and metabolic disease. Here, DIO2 is linked to metabolic disease.